A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer’s dementiaShifu Xiao, Raoli He, Weihong Kuang et al.|Alzheimer s Research & Therapy|2021Cited by 200
Clinical outcomes of COVID-19 in Wuhan, China: a large cohort studyJiao Liu, Dechang Chen, SiSi Huang et al.|Annals of Intensive Care|2020Cited by 146
Efficacy and safety of Paxlovid in severe adult patients with SARS-Cov-2 infection: a multicenter randomized controlled studyJiao Liu, Dechang Chen, Tangkai Qi et al.|The Lancet Regional Health - Western Pacific|2023Cited by 112
Association of sex with clinical outcomes in COVID-19 patients: A retrospective analysis of 1190 casesJiao Liu, Dechang Chen, Xiaofei Ye et al.|Respiratory Medicine|2020Cited by 22
Risk factors for secondary hemophagocytic lymphohistiocytosis in severe coronavirus disease 2019 adult patientsMei Meng, Dechang Chen, Yanxia Huang et al.|BMC Infectious Diseases|2021Cited by 21